Evaluation of the Efficacy of a New Specific Infant Formula in Case of Functional Constipation - Trial NCT05340712
Access comprehensive clinical trial information for NCT05340712 through Pure Global AI's free database. This phase not specified trial is sponsored by United Pharmaceuticals and is currently Recruiting. The study focuses on Functional Constipation. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
United Pharmaceuticals
Timeline & Enrollment
N/A
Jul 20, 2022
Sep 01, 2024
Primary Outcome
Hard stool consistency or painful defecation
Summary
This study aims to assess the clinical efficacy, safety and tolerance of a new formula
 containing a prebiotic and a mix of probiotics in the specific population of infants
 suffering from functional constipation through a superiority, double-blind, randomized,
 placebo-controlled trial.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05340712
Non-Device Trial